Bipindogulomethyloside

Metabolite details

Identifier

WRORFDCUNLGVJF-UHFFFAOYSA-N

InChI Key

WRORFDCUNLGVJF-UHFFFAOYSA-N

IUPAC name

3-[5,11,14-trihydroxy-10,13-dimethyl-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-uran-5-one

Preferred name

Bipindogulomethyloside

INN name

—

Synonym

—

ChEBI

CHEBI:176017

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Comparative Metabolomic Profiling of Compatible and Incompatible Interactions Between Potato and Phytophthora infestans
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• 2:00 AM_Membrane_vs_2:00 AM_Net
• Ziyun_No.1_0h_vs_Ziyun_No.1_96h
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose